Ana Vega
- Epidemiology
- Molecular Medicine top 10%
- Applied Microbiology and Biotechnology top 5%
- Infectious Diseases
- Pharmacology
- Co-authors
- Emily L. HeilKimberly C. ClaeysMelissa E. BadowskiJennifer BaileyLilian M. AbboPaul Msanzya ZuluLuis Escosa‐GarcíaOctavio Martínez
- Topics
- Antibiotic Resistance in Bacteria (7 papers)Antibiotic Use and Resistance (4 papers)Bacterial Identification and Susceptibility Testing (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesZambiaSpain
In The Last Decade
Ana Vega
19 papers receiving 160 citations
Peers
Comparison fields: 5 of 44
- Epidemiology 62
- Molecular Medicine 60
- Applied Microbiology and Biotechnology 55
- Infectious Diseases 53
- Pharmacology 33
Countries citing papers authored by Ana Vega
This map shows the geographic impact of Ana Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vega more than expected).
Fields of papers citing papers by Ana Vega
This network shows the impact of papers produced by Ana Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vega. The network helps show where Ana Vega may publish in the future.
Co-authorship network of co-authors of Ana Vega
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Vega. A scholar is included among the top collaborators of Ana Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Vega. Ana Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 29 | |
| 8 | 24 | |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 3 | |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 28 | |
| 16 | 2 | |
| 17 | 2 | |
| 18 | 33 | |
| 19 | Commentary on Current Trends in Rising Drug Costs and Reimbursement Below Cost. | 5 |
About Ana Vega
Ana Vega is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 19 papers that have together received 163 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (55 citations), Molecular Medicine (60 citations) and Clinical Biochemistry (25 citations). Ana Vega has collaborated with scholars based in United States, Zambia and Spain. Frequent co-authors include Emily L. Heil, Kimberly C. Claeys, Melissa E. Badowski, Jennifer Bailey, Lilian M. Abbo, Paul Msanzya Zulu, Luis Escosa‐García, Octavio Martínez, Sombo Fwoloshi and Esther Ramos Boluda. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.